P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

• Linyu Yuan,
• Suo Xiaohui,
• Guanchen Bai,
• Hong LI,
• Zhongjing Han,
• Congcong Zhang,
• Yinling LI,
• Sifeng Gao,
• Jilei Zhang,
• Xinxiao Lu,
• Kaiqi Liu,
• Zhao Xingli

Affiliations

Linyu Yuan

1 Tianjin People’s Hospital, Department of Hematology, Tianjin, China

Suo Xiaohui

2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China

Guanchen Bai

3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China

Hong LI

4 Daqing Oilfield General Hospital, Department of Hematology, Daqing，Heilongjing, China

Zhongjing Han

4 Daqing Oilfield General Hospital, Department of Hematology, Daqing，Heilongjing, China

Congcong Zhang

2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China

Yinling LI

2 Handan Central Hospital, Department of Hematology, Handan, Hebei, China

Sifeng Gao

3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China

Jilei Zhang

3 The Affiliated Tai’an City Central Hospital of Qingdao University, Department of Hematology, Taian, Shandong, China

Xinxiao Lu

5 Tianjin People’s Hospital, Department of Hematology, Tianjin, China

Kaiqi Liu

6 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, leukemia center, Tianjin, China

Zhao Xingli

5 Tianjin People’s Hospital, Department of Hematology, Tianjin, China